11th International Autoimmunity Seminar: Advancing Insights and Collaboration in Autoimmune Research

11thIAS

The 11th International Autoimmunity Seminar, held on November 5-6, 2024, in Riyadh, Saudi Arabia, brought together over 70 delegates from across the EEMEA region.

The seminar served as a platform to share the latest advancements and foster collaboration in the field of autoimmunity.

The event opened with a discussion on the role of antinuclear antibodies (ANA) as a crucial entry criterion for the classification of Systemic Lupus Erythematosus (SLE). ANA positivity, observed in approximately 95% of individuals with SLE, is an essential diagnostic marker, even in the absence of other clinical symptoms. A subsequent lecture focused on the clinical manifestations and management of pediatric patients with connective tissue diseases (CTDs).

The discussion emphasized how specific CTDs, including SLE, juvenile idiopathic arthritis (JIA), scleroderma, dermatomyositis, and mixed connective tissue disease (MCTD), influence treatment strategies and outcomes in children.

The seminar then delved into the International Consensus on ANA Patterns (ICAP). Initiated in 2014–2015, ICAP introduced harmonized guidelines for interpreting ANA test results using the indirect immunofluorescence assay on HEp-2 cells (HEp-2 IFA). Subsequent global meetings have further refined and promoted the classification of HEp-2 IFA patterns, enhancing the standardization of ANA reporting.

A session on novel biomarkers for autoimmune inflammatory myositis highlighted the importance of antibody profiles in undifferentiated connective tissue disease (UCTD). It also showcased innovative findings using Particle-Based Multi-Analyte Technology (PMAT) for diagnosing and managing CTDs.

An insightful session on Rheumatoid Arthritis (RA), underscoring the urgent need for standardizing biomarker criteria. The session also emphasized the development of novel autoantibodies to improve patient stratification and therapeutic decision-making. The final session focused on gastrointestinal autoimmunity, providing new insights into celiac disease, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis.

The seminar’s diverse discussions and international participation underscored its importance in advancing research and collaboration in autoimmunity. Such success would not have been possible without the contributions of the EEMEA team, including Autoimmunity Team Members, Marketing Colleagues, the Communication Department, Assistants, and Commercial Teams. We extend our gratitude to all participants and look forward to welcoming you to the 12th International Autoimmunity Seminar.

EEMEA Marketing Team

Last modified on Tuesday, 24 February 2026 11:51

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top